This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

News

Angi Calkins Appointed as Chief Human Resources Officer

Calkins to lead global human resource team during time of considerable expansion

PCI is pleased to announce the appointment of Angi Calkins as Senior Vice President and Chief Human Resources Officer. Angi joins PCI as we experience considerable growth and global expansion, currently with more than 3,500 associates, spanning eight locations comprised of 20 facilities across three continents. PCI features a broad portfolio of outsourced development and commercialization services focused in drug development and manufacturing, clinical trial supply, as well as commercial contract packaging.

Angi brings significant experience to PCI gained during an impressive career in human resources leadership across multiple and diverse industries including pharmaceutical and life sciences, retail, consumer goods, global HR outsourcing and financial services. Angi joins us having served in senior leadership roles at Regeneron Pharmaceuticals, a leading biotechnology company that doubled in size, was recognized each year by Forbes as one of the 100 Greatest Places to Work, and was ranked the industry’s number one Biopharma Employer by Science Magazine during three of her four years in post

Commenting on Angi’s appointment, Chief Executive Officer Salim Haffar noted: “PCI is at a transformative time. We have a celebrated history of partnering with leading pharmaceutical and biotech companies to support bringing their life-saving medicines to patients around the world. Building on those trusted relationships, over the past 12 months we have changed the complexion of the company with acquisitions in key geographies including Dublin, Ireland; Melbourne, Australia; and San Diego, California, bringing new capabilities and greater access to global emerging markets.

Our company is rich in cutting-edge science and technology, rooted in a dedication to outstanding service and quality. This is achieved through a talented and dedicated workforce. I am very pleased to have Angi join at such an exciting time and am eager to see her insights and leadership help shape the future of the company.

I am delighted for this opportunity,” stated Angi. “Across my career I have had opportunities to learn about and excel in both in-house and outsource partnership organizations, and PCI is a uniquely inspiring fit for my background and my passion for people and talent at the heart of great business. I was attracted to PCI by virtue of its outstanding reputation in the industry, its focus on continued investment and global growth, and certainly its singular commitment to delivering outstanding service and industry-leading quality for its clients, ultimately playing a critical role in the lives of our clients’ patients around the world. PCI has demonstrated through its investments and focus on developing a growing global workforce that it is committed to meeting the unique and ever-evolving needs of its clients, both in the short- and the long-term. I am excited to be part of that growth and expansion.”

In addition to key acquisitions in Melbourne, Australia and San Diego, California, we recently broke ground on site expansion at our Rockford, Illinois facility. This complements recently executed site expansions at our European clinical Center of Excellence in Bridgend and our manufacturing Center of Excellence in Tredegar, UK as well as investments at sites in Dublin, Ireland; Hay-on-Wye, UK; and Philadelphia, PA.

January 28, 2019


PCI Unveils Clinical Center of Excellence

Expanded Clinical Services Facility in Rockford, IL to Support Growth and Flexibility with 30,000 additional sq ft We have officially... View Article

Significant Investments at Ireland Site

PCI Strengthens Position in Europe with Investment in Ireland Latest development at Dublin site positions it at forefront of EU... View Article

x